Dual-specificity phosphatase 1 and serum
β
Hanna E. Rauhala; Kati P. Porkka; Teemu T. Tolonen; Paula M. Martikainen; Teuvo
π
Article
π
2005
π
John Wiley and Sons
π
French
β 288 KB
## Abstract Inactivation of tumor suppressor genes through deletion, mutation and epigenetic silencing has been shown to occur in cancer. In our study, we combined DNA demethylation and histone deacetylation inhibition treatments with suppression subtraction hybridization (SSH) and cDNA microarrays